Literature DB >> 21708432

Application of failure mode and effects analysis to intraoperative radiation therapy using mobile electron linear accelerators.

Mario Ciocca1, Marie-Claire Cantone, Ivan Veronese, Federica Cattani, Guido Pedroli, Silvia Molinelli, Viviana Vitolo, Roberto Orecchia.   

Abstract

PURPOSE: Failure mode and effects analysis (FMEA) represents a prospective approach for risk assessment. A multidisciplinary working group of the Italian Association for Medical Physics applied FMEA to electron beam intraoperative radiation therapy (IORT) delivered using mobile linear accelerators, aiming at preventing accidental exposures to the patient. METHODS AND MATERIALS: FMEA was applied to the IORT process, for the stages of the treatment delivery and verification, and consisted of three steps: 1) identification of the involved subprocesses; 2) identification and ranking of the potential failure modes, together with their causes and effects, using the risk probability number (RPN) scoring system, based on the product of three parameters (severity, frequency of occurrence and detectability, each ranging from 1 to 10); 3) identification of additional safety measures to be proposed for process quality and safety improvement. RPN upper threshold for little concern of risk was set at 125.
RESULTS: Twenty-four subprocesses were identified. Ten potential failure modes were found and scored, in terms of RPN, in the range of 42-216. The most critical failure modes consisted of internal shield misalignment, wrong Monitor Unit calculation and incorrect data entry at treatment console. Potential causes of failure included shield displacement, human errors, such as underestimation of CTV extension, mainly because of lack of adequate training and time pressures, failure in the communication between operators, and machine malfunctioning. The main effects of failure were represented by CTV underdose, wrong dose distribution and/or delivery, unintended normal tissue irradiation. As additional safety measures, the utilization of a dedicated staff for IORT, double-checking of MU calculation and data entry and finally implementation of in vivo dosimetry were suggested.
CONCLUSIONS: FMEA appeared as a useful tool for prospective evaluation of patient safety in radiotherapy. The application of this method to IORT lead to identify three safety measures for risk mitigation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21708432     DOI: 10.1016/j.ijrobp.2011.05.010

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  17 in total

1.  The report of Task Group 100 of the AAPM: Application of risk analysis methods to radiation therapy quality management.

Authors:  M Saiful Huq; Benedick A Fraass; Peter B Dunscombe; John P Gibbons; Geoffrey S Ibbott; Arno J Mundt; Sasa Mutic; Jatinder R Palta; Frank Rath; Bruce R Thomadsen; Jeffrey F Williamson; Ellen D Yorke
Journal:  Med Phys       Date:  2016-07       Impact factor: 4.071

2.  Redesign of process map to increase efficiency: Reducing procedure time in cervical cancer brachytherapy.

Authors:  Antonio L Damato; Larissa J Lee; Mandar S Bhagwat; Ivan Buzurovic; Robert A Cormack; Susan Finucane; Jorgen L Hansen; Desmond A O'Farrell; Alecia Offiong; Una Randall; Scott Friesen; Akila N Viswanathan
Journal:  Brachytherapy       Date:  2015-01-06       Impact factor: 2.362

3.  An FMEA evaluation of intensity modulated radiation therapy dose delivery failures at tolerance criteria levels.

Authors:  Jacqueline Tonigan Faught; Peter A Balter; Jennifer L Johnson; Stephen F Kry; Laurence E Court; Francesco C Stingo; David S Followill
Journal:  Med Phys       Date:  2017-10-19       Impact factor: 4.071

4.  Multi-institutional application of Failure Mode and Effects Analysis (FMEA) to CyberKnife Stereotactic Body Radiation Therapy (SBRT).

Authors:  Ivan Veronese; Elena De Martin; Anna Stefania Martinotti; Maria Luisa Fumagalli; Cristina Vite; Irene Redaelli; Tiziana Malatesta; Pietro Mancosu; Giancarlo Beltramo; Laura Fariselli; Marie Claire Cantone
Journal:  Radiat Oncol       Date:  2015-06-13       Impact factor: 3.481

5.  In vivo dosimetry and shielding disk alignment verification by EBT3 GAFCHROMIC film in breast IOERT treatment.

Authors:  Mara Severgnini; Mario de Denaro; Marina Bortul; Cristiana Vidali; Aulo Beorchia
Journal:  J Appl Clin Med Phys       Date:  2014-01-08       Impact factor: 2.102

6.  Failure mode and effects analysis: A community practice perspective.

Authors:  Bradley W Schuller; Angi Burns; Elizabeth A Ceilley; Alan King; Joan LeTourneau; Alexander Markovic; Lynda Sterkel; Brigid Taplin; Jennifer Wanner; Jeffrey M Albert
Journal:  J Appl Clin Med Phys       Date:  2017-09-25       Impact factor: 2.102

7.  Application of failure mode and effects analysis to treatment planning in scanned proton beam radiotherapy.

Authors:  Marie Claire Cantone; Mario Ciocca; Francesco Dionisi; Piero Fossati; Stefano Lorentini; Marco Krengli; Silvia Molinelli; Roberto Orecchia; Marco Schwarz; Ivan Veronese; Viviana Vitolo
Journal:  Radiat Oncol       Date:  2013-05-24       Impact factor: 3.481

8.  Application of failure mode and effects analysis (FMEA) to pretreatment phases in tomotherapy.

Authors:  Sara Broggi; Marie Claire Cantone; Anna Chiara; Nadia Di Muzio; Barbara Longobardi; Paola Mangili; Ivan Veronese
Journal:  J Appl Clin Med Phys       Date:  2013-09-06       Impact factor: 2.102

9.  Dosimetric characteristics of electron beams produced by two mobile accelerators, Novac7 and Liac, for intraoperative radiation therapy through Monte Carlo simulation.

Authors:  Sergio Righi; Evis Karaj; Giuseppe Felici; Fabio Di Martino
Journal:  J Appl Clin Med Phys       Date:  2013-01-07       Impact factor: 2.102

10.  FMECA Application to Intraoperative Electron Beam Radiotherapy Procedure As a Quality Method to Prevent and Reduce Patient's Risk in Conservative Surgery for Breast Cancer.

Authors:  Cristiana Vidali; Mara Severgnini; Monica Urbani; Licia Toscano; Alfredo Perulli; Marina Bortul
Journal:  Front Med (Lausanne)       Date:  2017-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.